Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

Human metapneumovirus is similar to respiratory syncytial virus (RSV) and primarily affects children 5 years old and younger, Sobolewski said. However, adults, especially older adults, can also ...

The recent surge in influenza cases in the Triad and statewide has led to an increase in flu-related deaths, including two ...

Cases of influenza continue to soar across Canada, meanwhile rates of respiratory syncytial virus, or RSV, and COVID-19 are ...

(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...

MIDLAND, Texas — A recent outbreak of various respiratory diseases has been spreading throughout West Texas. This includes COVID-19, influenza AKA the flu, and respiratory syncytial virus, or RSV.

ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimize the impact of viral respiratory infections, announces today it has received a ...